C2N Diagnostics
Saint Louis, MO, US· latest recorded location
C2N Diagnostics is named on 5 US grants and 10 published applications in this corpus. Its most frequent classification is G01N (Investigating or analysing materials by determining their chemical or physical properties).
- Granted patents
- 5
- Published applications
- 10
- Inventors
- 15
- Granted in 2026 so far
- 0
- Most recent grant
- 18 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 3 |
| 2015 | 0 | 0 |
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 2 |
| 2019 | 2 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Technology areas
Share of 15 documents
- G01NInvestigating or analysing materials by determining their chemical or physical properties12
- A61PTherapeutic uses of medicines8
- A61KMedicines and medical preparations3
- C07KPeptides3
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or2
- C12NMicroorganisms or enzymes1
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1
Recent patents
- Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes18 Mar 2025US 12,253,529 B2
- Methods for measuring concentrations of biomolecules in biofluids13 Apr 2021US 10,976,323 B2
- Methods for measuring concentrations of biomolecules19 Nov 2019US 10,481,167 B2
- Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes16 Apr 2019US 10,261,097 B2
- Humanized anti-tau antibodies1 May 2018US 9,957,317 B2
- Stable formulations of humanized anti-tau antibody30 Jan 2020US 2020/0030445 A1
- Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes4 Jul 2019US 2019/0204344 A1
- Humanized anti-tau antibodies27 Dec 2018US 2018/0371066 A1
- Methods for extracting and measuring concentrations of biomolecules in complex matrices without the need for immunocapture20 Dec 2018US 2018/0364260 A1
- Methods for the Diagnosis and Treatment of Neurological and Neurodegenerative Diseases, Disorders and Associated Processes27 Oct 2016US 2016/0313353 A1
Most cited
By later US patents